Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted M Burns

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Neurology|May 5, 2010
The MG Composite: A valid and reliable outcome measure for myasthenia gravisTed M Burns, Mark Conaway, Donald B Sanders, et al.
The Journal of Family Practice|October 4, 2006
An easy approach to evaluating peripheral neuropathyJeffrey M Burns, Michelle L Mauermann, Ted M Burns
Muscle & Nerve|July 30, 2020
A crisis in US drug pricing: Consequences for patients with neuromuscular diseases, physicians and society, part 1Ted M Burns, Jason L Crowell, A Gordon Smith
Neurology|September 25, 2003
Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjögren's syndromeTed M Burns, Susana Quijano-Roy, H Royden Jones
Neurology|January 26, 2005
Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodiesTed M Burns, Lawrence H Phillips, H R Jones
Muscle & Nerve|July 30, 2020
A crisis in US drug pricing: Consequences for patients with neuromuscular diseases, physicians, and society, part 2Ted M Burns, Jason L Crowell, A Gordon Smith
Muscle & Nerve|October 19, 2011
MG-ADL: still a relevant outcome measureSrikanth Muppidi, Gil I Wolfe, Mark Conaway, et al.
Neurologic Clinics|February 28, 2007
Vasculitic neuropathiesTed M Burns, Gregory A Schaublin, P James B Dyck
Muscle & Nerve|May 31, 2012
Quality of life and measures of quality of life in patients with neuromuscular disordersTed M Burns, Christopher D Graham, Michael R Rose, et al.
Neurology|October 13, 2006
Improvement with corticosteroids and azathioprine in GAD65-associated cerebellar ataxiaNikolaus R McFarland, Ivan S Login, Samuel Vernon, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Neurology|May 5, 2010
The MG Composite: A valid and reliable outcome measure for myasthenia gravisTed M Burns, Mark Conaway, Donald B Sanders, et al.
The Journal of Family Practice|October 4, 2006
An easy approach to evaluating peripheral neuropathyJeffrey M Burns, Michelle L Mauermann, Ted M Burns
Muscle & Nerve|July 30, 2020
A crisis in US drug pricing: Consequences for patients with neuromuscular diseases, physicians and society, part 1Ted M Burns, Jason L Crowell, A Gordon Smith
Neurology|September 25, 2003
Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjögren's syndromeTed M Burns, Susana Quijano-Roy, H Royden Jones
Neurology|January 26, 2005
Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodiesTed M Burns, Lawrence H Phillips, H R Jones
Muscle & Nerve|July 30, 2020
A crisis in US drug pricing: Consequences for patients with neuromuscular diseases, physicians, and society, part 2Ted M Burns, Jason L Crowell, A Gordon Smith
Muscle & Nerve|October 19, 2011
MG-ADL: still a relevant outcome measureSrikanth Muppidi, Gil I Wolfe, Mark Conaway, et al.
Neurologic Clinics|February 28, 2007
Vasculitic neuropathiesTed M Burns, Gregory A Schaublin, P James B Dyck
Muscle & Nerve|May 31, 2012
Quality of life and measures of quality of life in patients with neuromuscular disordersTed M Burns, Christopher D Graham, Michael R Rose, et al.
Neurology|October 13, 2006
Improvement with corticosteroids and azathioprine in GAD65-associated cerebellar ataxiaNikolaus R McFarland, Ivan S Login, Samuel Vernon, et al.
Pageof 9